Jeffrey Stout
Interventional Cardiology · Germantown, TNNPI 1063528198
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 270 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,696 and has fallen 91.8% since, to $139 in 2025. That places this record below the midpoint for interventional cardiology clinicians in TN, where the typical reported total is $7,646.
Across 270 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$824
- Novartis$543
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$444
- Medtronic$435
- Johnson & Johnson$367
- Amgen$232
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,569100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 41 | $824 |
| Novartis | 30 | $543 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 26 | $444 |
| Medtronic(2 entities) | 27 | $435 |
| Johnson & Johnson | 28 | $367 |
| Amgen | 16 | $232 |
| Merck | 11 | $187 |
| Sanofi-aventis U.S. LLC | 11 | $182 |
| Boehringer Ingelheim | 10 | $163 |
| AstraZeneca | 8 | $147 |
| Astellas Pharma US Inc | 7 | $146 |
| Amarin Pharma, Inc. | 7 | $140 |
| Pfizer | 10 | $130 |
| Regeneron Healthcare Solutions, Inc. | 8 | $108 |
| Abiomed | 4 | $107 |
| Gilead | 4 | $62 |
| Boston Scientific | 2 | $56 |
| Chiesi USA, Inc. | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $39 |
| Portola Pharmaceuticals, LLC | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Novo Nordisk | 2 | $32 |
| Bardy Diagnostics, Inc. | 2 | $30 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Philips North America LLC | 1 | $17 |
| Atricure, Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,580 in reported general payments places this provider in the 30th percentile of 207 interventional cardiology providers in Tennessee.
Other interventional cardiology in Germantown
- Mehul PatelGermantown$382K
- David KrausGermantown$87K
- Basil PaulusGermantown$67K
- James KlemisGermantown$24K
- Justin MayGermantown$23K
- Tamunoinemi Bob-ManuelGermantown$22K
- Milton AddingtonGermantown$15K
- Jimmy KerriganNashville$644K
- Kashish GoelNashville$558K
- Brian JeffersonNashville$547K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.